¿Cuánto es demasiado? Solamente por la vacuna contra la neumonía, Pfizer y GSK han ganado un total combinado de 25 mil millones dólares Muchos países no pueden afrontar el costo de la vacuna contra la neumonía, y no podemos darnos el lujo de dejar que Pfizer y GSK sigan fijando los precios de la vacuna fuera de su alcance. Con casi un millón de niños muriendo de neumonía cada año, tenemos que reducir los precios AHORA. Comparte este vídeo y ayúdanos a pedirles que bajen el precio de la vacuna contra la neumonía a ¡$ 5 dólares por niño! #AskPharma+ More details
How much is too much? Pfizer and GSK have made a combined total of $25 billion from the pneumonia vaccine alone. Many countries can't afford the pneumonia vaccine, and we can't afford to let Pfizer and GSK continue pricing the vaccine out of reach. With almost one million children dying of pneumonia each year, we need lower prices NOW. Share this video and help us #AskPharma to lower the price of the pneumonia vaccine to $5/child! https://bitly.com/1I4Vt61+ More details
Seven videos around theme of obstacles to immunization, created out of shooting interviews at MSF Vaccines conference in Norway, indispersed with footage from the field to highlight key areas of concern in our Vaccines advocacy dossier. Initially commissioned for and shared with everyone who went to the conference,later sent around more widely to academics/researchers/civil society. Well received. HOW CAN WE REACH MORE CHILDREN WITH VACCINES? Vaccines are not developed originally for children living in poor countries. Many of them – requiring, for instance, refrigerated transportation and storage – are therefore not suited to the conditions of many countries where temperatures can soar above 40C (104F) and where electricity is often intermittent. Stimulating the development of better adapted vaccines is key to improving access to immunisation.+ More details
COMPLETING THE IMMUNISATION SCHEDULE In many countries, national immunisation guidelines set out the timetable for childhood vaccination within the first year of life. If the child fails to complete the full set of recommended vaccines by 11 months, there are often no provisions to allow the child to “catch up” on missed vaccinations. While WHO recommends that children older than one year should still be vaccinated in order to complete the immunisation series, this is often not implemented in countries due to concerns about stock outs and as international donors do not usually purchase EPI vaccines for older age groups. Countries and international organisations should implement the WHO recommendations and make sure that children complete their immunisation series, even if they are older than one year.+ More details
Seven videos around theme of obstacles to immunization, created out of shooting interviews at MSF Vaccines conference in Norway, indispersed with footage from the field to highlight key areas of concern in our Vaccines advocacy dossier. Initially commissioned for and shared with everyone who went to the conference,later sent around more widely to academics/researchers/civil society. AFFORDABLE VACCINES New vaccines are much more expensive than older vaccines. Two of the newest vaccines – against pneumonia and diarrhoea – account for more than 70% of the total cost of vaccinating a child. Reasons for this include a very restricted number of manufacturers in the market resulting in a lack of competition to drive prices down, and a continuing lack of transparency by the vaccine industry over the costs to develop and manufacture vaccines. Greater efforts are needed by GAVI and other major vaccine purchasers, to use their market weight in negotiating more affordable vaccines.+ More details
ENGAGING CIVIL SOCIETY Civil Society Organisations are key to supporting Ministries of Health to improve access to vaccination. CSOs play a variety of roles, including direct service delivery, engaging with the most marginalised and hard-to-reach populations and creating demand for vaccination. In the area of advocacy, civil society groups can push governments to be more accountable to their people while influencing global organisations’ support to countries to make it as effective as possible. The role of civil society groups in the most affected countries is particularly important and must be strengthened – at community, national, regional and international level.+ More details
REACHING NEGLECTED POPULATIONS While overall progress on improving immunisation coverage has been positive, figures often mask underlying inequities between and within countries. Entire populations may be isolated by conflict, geography or simply extreme poverty, and therefore remain beyond the reach of adequate immunisation services. At the same time, even within richer and more stable countries, where access to immunisation is broadly available, there are communities who are not being reached. Developing and improving policies that are specific to neglected populations – such as refugees, the urban or rural poor, communities living in remote areas, and others – is key to ensuring all people benefit from vaccination.+ More details
REACHING ALL CHILDREN WITH VACCINES Middle Income Countries (MICs) constitute more than 70% of the world’s population. Criteria for access to GAVI Alliance support is based on traditional measures of gross national income (GNI), which excludes the unimmunised living in many middle-income countries. This leaves some vulnerable populations without access to new vaccines. Middle-income countries are often left to negotiate vaccine prices without the help of international actors. As a result, some of these countries are struggling to afford the more expensive new vaccines so that their children can benefit, as well.+ More details
GRADUATION There are 17 countries currently receiving support and subsidies from GAVI that are due to lose this support by 2016, a process called “graduation.” More countries are entering the graduation process each year. There are concerns that, following the withdrawal of support, countries may not be able to continue to sustain the use of new vaccines, particularly if they are unable to purchase those vaccines at the lower prices that GAVI has negotiated with industry. Graduation is based on per capita GNI – which may not directly reflect massive health and vaccine coverage inequities within countries.+ More details
What are Tags?
Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."